-transparent.png){kind=logo}
We evaluated the use of danazol in 15 patients with autoimmune hemolytic anemia of the warm antibody type. Danazol, 600 to 800 mg/d, was added to previous regimens or given initially in conjunction with high-dose prednisone treatment. Twelve patients with autoimmune hemolytic anemia associated with nonmalignant disorders or idiopathic autoimmune hemolytic anemia and 1 of 3 patients with underlying neoplasms showed a rise in hematocrit within 1 to 3 weeks. Thereafter, glucocorticoid doses were tapered to a minimum requirement or stopped. Once remission was sustained, the dose of danazol was reduced to 200 to 400 mg/d. Although levels of erythrocyte-bound IgG antibody and C3 decreased with therapy, only the decrease in C3 was statistically significant (p less than 0.05) in this limited study. Danazol was effective regardless of the severity of the disorder and success or failure of previous treatments. Danazol is valuable in the treatment of autoimmune hemolytic anemia and may be better suited than glucocorticoids for long-term management.
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
February 1991,
The Journal of rheumatology,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
February 1990,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
October 1976,
Seminars in hematology,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
June 1986,
The Journal of pediatrics,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
September 1992,
Presse medicale (Paris, France : 1983),
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
October 1976,
Seminars in hematology,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
December 1994,
Hematology/oncology clinics of North America,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
October 2006,
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
November 1989,
Annals of the Academy of Medicine, Singapore,
Y S Ahn, and
W J Harrington, and
R Mylvaganam, and
J Ayub, and
L M Pall
July 2023,
Clinical and experimental medicine,
